Renew Biotechnologies

Renew Biotechnologies Named 2026 "Biomarker Discovery Platform of the Year" by BioTech Breakthrough

Recognition highlights Renew's NeuroLens™ platform and its approach to investigating cell-type-specific biomarkers for neurodegenerative disease…